# Growth And Safety Outcomes In Infants With Cow´s Milk Protein Allergy (CMPA) Fed A Novel Extensively Hydrolyzed Formula (eHF)

> **NCT07711938** · NA · NOT_YET_RECRUITING · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 410 (estimated)

## Conditions studied

- Cow Milk Protein Allergy

## Interventions

- **DIETARY_SUPPLEMENT:** New generation eHF
- **DIETARY_SUPPLEMENT:** Commercial eHF

## Key facts

- **NCT ID:** NCT07711938
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2028-07-31
- **Final completion:** 2029-05-30
- **Target enrollment:** 410 (ESTIMATED)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07711938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07711938, "Growth And Safety Outcomes In Infants With Cow´s Milk Protein Allergy (CMPA) Fed A Novel Extensively Hydrolyzed Formula (eHF)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07711938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*